Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data. حسب Soheila Qanbari (20455173)

الموضوعات:

The 160 differentially expressed proteins significantly elevated in the severe injury group compared to the mild injury group and their folding changes. حسب Huiyang Jia (14444661)

Top 10 significantly changed metabolites and lipids in each clinical outcome measure group. حسب Patricia Sikorski (1320966)

"…The orange color indicates increase in levels and the blue color represent decrease in levels. (A) MMS status, yes vs. no (B) change in (Δ) QMG (> 40% vs. < 0%) (C) change in (Δ) MG-ADL (> 40% vs. < 0%), (D) Responder versus Non-Responder. …"

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Inotodiol decreases clone formation in HCC cells. حسب Yushuang Xing (20636685)

"…Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. …"

NSG mice engrafted with hPBMCs do not show significant body weight changes up to 10 weeks post hPBMC injection. حسب Tingting Huang (496866)

Pathway analysis using GRB2, a significantly connected and downregulated protein as the focus. حسب Eiman Y. Ibrahim (10731078)

Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-t... حسب Emir Matpan (21655811)

Changes of bacterial community. حسب Xuan Gao (130773)

الموضوعات:

List of 421 genes whose expression is increased by galactose and decreased by any of the HAT inhibitors. حسب Masaya Nagaya (13851123)

The hypoxia-induced changes of endothelial and fibrotic markers. حسب Jing Mao (148640)

الموضوعات:

Significant Lipids by Category- Tiers 1 and 2. حسب Keenan Elliott (17181211)

Associations between changes in TCC and changes in selected variables after 6 months of treatment. حسب Thao H. P. Nguyen (11027765)

الموضوعات:

Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- حسب Wencheng Jin (13136262)

Treatment with ICs causes a significant decrease in podocyte proliferation. حسب George Haddad (470789)

Changes in TCC with MTX monotherapy and TNFi±MTX treatment. حسب Thao H. P. Nguyen (11027765)

الموضوعات:

Results of Analysis of Co-variance (ANCOVA) for change in parameter predicted by treatment group with pre-treatment value as a covariate. * p < 0.05; ** p < 0.01. حسب Lijuan Liu (136685)

الموضوعات:

The ARGs changed along the WWTPs process. حسب Xuan Gao (130773)

الموضوعات:

Comparison of outpatient expenditure of the treatment and comparison groups before and after PSM (RMB). حسب Long Xue (10926423)

الموضوعات: